Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-639-5 | CAS number: 7664-93-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Carcinogenicity
Administrative data
Description of key information
A number of studies of the carcinogenicity of sulphuric acid have been performed using oral gavage, intratracheal instillation and inhalation exposure. A published review of the available animal data is also available.
Key value for chemical safety assessment
Carcinogenicity: via oral route
Link to relevant study records
- Endpoint:
- carcinogenicity
- Remarks:
- other: gavage and intratracheal instillation
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Non-guideline, published study
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- no guideline followed
- Deviations:
- not applicable
- Principles of method if other than guideline:
- This study was conducted to determine whether sulphuric acid is a causal or contributory factor to carcinogenesis in the rat and mouse.
- GLP compliance:
- no
- Remarks:
- Published study
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Route of administration:
- other: gavage and intratracheal instillation
- Vehicle:
- water
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- Lifetime
- Frequency of treatment:
- Various (see method details)
- Post exposure period:
- Not applicable
- No. of animals per sex per dose:
- 30
- Control animals:
- yes, concurrent no treatment
- Relevance of carcinogenic effects / potential:
- The results of this study suggest a weak and local carcinogenic activity of sulphuric acid in the rat on the oesophagus/forestomach (following gavage administration) and on the respiratory tract (following intratracheal instillation). Findings also indicate that co-administration of sulphuric acid may increase the potency of a known genotoxic carcinogen.
- Dose descriptor:
- NOAEL
- Effect level:
- other: 0.5 mL of 0.6% aqueous solution per day
- Sex:
- male/female
- Basis for effect level:
- other: Benign stomach tumours.
- Remarks on result:
- not determinable
- Remarks:
- no NOAEL identified. Effect type:carcinogenicity (migrated information)
- Conclusions:
- Some evidence of a weak local carcinogenic activity was seen under the conditions of this study.
- Executive summary:
Rats (30/sex) were administered sulphuric acid by gavage (weekly) or by intratracheal instillation (twice monthly) for life. Additional groups were untreated or were instilled with benzo(a)pyrene or with sulphuric acid/benzo(a)pyrene.
Gavage with sulphuric acid resulted in histopathological evidence of local irritation of the forestomach and slightly elevated incidences of benign forestomach tumours. Intratracheal instillation of sulphuric acid resulted in slightly increased incidences of respiratory tract tumours. Co-administration of benzo(a)pyrene resulted in increased incidences of respiratory tract tumours.
Reference
Survival of animals was shortest in the benzo(a)pyrene/sulphuric acid group (mean survival 96.1 +/- 5.4 weeks) and was longest in the untreated controls (111.4 +/- 3.7 weeks). The survival of female rats given sulphuric acid by gavage or instillation or benzo(a)pyrene only was longer than males. A small number of tumours were observed in the experimental groups during the first year of the study; whereas no tumours were observed in the control group. The first malignant tumour (generalised lymphosarcoma with expansion to lungs) was noted in the 34th week in a female rat administered benzo(a)pyrene and sulphuric acid by intratracheal instillation. The main pathological changes observed in dead or moribund animals during the first year were bronchitis and chronic pneumonia. During the second and third year of the study, various tumours appeared, both benign and malignant and mainly of the respiratory tract, forestomach and lymphoma. Rats gavaged with sulphuric acid had an increased (twice the controls) incidence of benign forestomach tumours (papillomas, micropapillomas); hyperplasia of the epithelium of the forestomach, hyperkeratosis and acanthosis were also observed in this group. Two malignant tumours of the forestomach (squamous cell carcinoma) were detected; one in the treated and one in the untreated control groups. One malignant lung tumour (adenocarcinoma) was observed in male rats gavaged with sulphuric acid. The animals instilled with sulphuric acid/benzo(a)pyrene) had a higher incidence of (and multiplicities of) malignant tumours compared to the untreated controls. Total incidences of malignant tumours were 33.9%, 30.8% and 7.0% in the groups treated with sulphuric acid, sulphuric acid/benzo(a)pyrene and controls respectively. The incidence of malignant respiratory tract tumours was highest in the group treated with sulphuric acid/benzo(a)pyrene; 6, 3 and 0 malignant tumours were observed in the groups treated with sulphuric acid/benzo(a)pyrene), sulphuric acid alone and controls respectively. Tumours appeared earlier in the group treated with sulphuric acid and benzo(a)pyrene, compared to the groups treated with benzo(a) pyrene or sulphuric acid alone (latency of 69, 86 and 95 weeks of treatment respectively). No lung tumours were observed in control rats. Both lymphomas (8,6,3) and malignant tumours at various sites (5,4,1) were seen more frequently in groups exposed by intratracheal instillation to sulphuric acid, sulphuric acid/benzo(a)pyrene compared to the untreated controls respectively. A small number of spontaneous tumours (mostly benign and mainly micropapillomas of the forestomach) were identified in the untreated control (22.8%) and India Ink control (28.6%) groups. The number of animals with malignant tumours (7%) in the untreated control group was lower.
Tumour incidences in the rat
Group |
Tumours (B, M) |
||||||||
Total |
Malignant |
Multiple |
Respiratory tract |
Oesophagus, forestomach |
Lymphoma |
Other |
|||
Sulphuric acid |
Gavage |
30 (M) |
33.3% |
7.4% |
3.7% |
-,1 |
8,- |
1 |
-,- |
30 (F) |
44.4% |
7.4% |
7.4% |
-,- |
8,- |
- |
3,2 |
||
60 (M/F) |
38.8%* |
7.4% |
5.6% |
-,1 |
16,1 |
1 |
3,2 |
||
Instillation |
30 (M) |
50.0% |
32.1% |
14.3% |
-,1 |
1,6 |
3 |
2,3 |
|
30 (F) |
50.0% |
35.7% |
21.4% |
1,2 |
2,6 |
5 |
2,2 |
||
60 (M/F) |
50.0%** |
33.9%** |
17.9%* |
1,3 |
3,12 |
8 |
4,5 |
||
Sulphuric acid + BP |
Instillation |
30 (M) |
33.3% |
16.7% |
8.3% |
-,2 |
2,7 |
1 |
-,- |
30 (F) |
50.0% |
42.9% |
21.4% |
-,4 |
4,4 |
5 |
2,4 |
||
60 (M/F) |
42.3%* |
30.8%** |
15.4%* |
-,6 |
6,11 |
6 |
2,4 |
||
BP |
Instillation |
30 (M) |
33.3% |
16.7% |
8.3% |
-,1 |
1,6 |
2 |
1,1 |
30 (F) |
28.0% |
28.0% |
12.0% |
-,2 |
2,3 |
3 |
-,3 |
||
60 (M/F) |
30.6%* |
22.4%* |
10.2%* |
-,3 |
3,9 |
5 |
1,4 |
||
Untreated controls |
- |
30 (M) |
14.8% |
3.7% |
3.7% |
-,- |
-,- |
1 |
1,- |
30 (F) |
30.0% |
10.0% |
6.7% |
-,- |
-,- |
2 |
2,1 |
||
60 (M/F) |
22.8% |
7.0% |
5.3% |
-,- |
-,- |
3 |
3,1 |
||
Ink controls |
Instillation |
15 (F) |
28.6% |
14.3% |
14.3% |
-,- |
-,- |
- |
1,3 |
*significantly different to controls (p<0.05); **P<0.01
m:malignant
b:benign
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Study duration:
- chronic
- Species:
- rat
- Quality of whole database:
- The database consists of an acceptable published study in rats and mice
Carcinogenicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Study duration:
- chronic
- Quality of whole database:
- A number of poorly reported non-standard published studies are available, along with two acceptable published reviews
Carcinogenicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The available animal data do not support the classification of sulphuric acid for carcinogenicity. Weak evidence of a local carcinogenic effect on the forestomach/oesophagus was seen following lifetime oral gavage of rats with sulphuric acid at the MTD. Similarly, some evidence of a local carcinogenic effect on the respiratory tract was seen in rats treated with sulphuric acid by intratracheal instillation over a lifetime. A synergistic effect was seen in animals instilled with sulphuric acid and benzo(a)pyrene. A weak local carcinogenic effect was also seen in mice gavaged with sulphuric acid at the MTD over a lifetime. In all cases, findings were associated with chronic irritation at the site of contact. Although a number of epidemiological studies report a link between exposure to sulphuric acid mists and laryngeal cancer, the individual studies are imprecise and often do not take sufficient account of confounding factors such as smoking and occupational exposure to other chemicals,
A number of studies (using various animal species) have not demonstrated any carcinogenic effect of inhalation exposure to sulphuric acid mists.
Additional information
Animal data
Studies in the rat and mouse were performed by Uleckiene & Griciute (1997). In the rat study, weekly lifetime gavage treatment with sulphuric acid (at the MTD) was associated with chronic irritation of the forestomach and oesophagus and slightly increased incidences of forestomach tumours. Administration of sulphuric acid by intratracheal instillation (twice monthly at the MTD) was associated with a slightly increased incidence of respiratory tract tumours; instillation of sulphuric acid also increased the incidence of respiratory tract tumours induced by benzo(a)pyrene. In the mouse study, gavage administration with sulphuric acid (weekly at the MTD) resulted in chronic local irritation of the forestomach and a slight increase in the incidence of benign forestomach tumours. The authors conclude that sulphuric acid is a weak, local carcinogen that may act synergistically with other locally acting carcinogens.
In a study in hamsters (Laskin & Sellakumar, 1978), the effect of exposure to the known carcinogen benzo(a)pyrene (administered by intratracheal instillation) and sulphuric acid (by inhalation) was investigated. No evidence of respiratory tract carcinogenicity was seen in animals exposed for a lifetime to sulphuric acid mist (100 mg/m/3; 6 hours/day, 5 days/week). Clear evidence of respiratory tract carcinogenicity was seen in animals exposed to benzo(a)pyrene, alone and in combination with sulphuric acid; however there was no evidence for co-carcinogenicity in animals exposed to the two compounds.
No effects of exposure to sulphuric acid mists (10 mg/m3) or ozone (0.5 ppm) alone or in combination was seen in rats or guinea pigs exposed for two years (Experimental Pathology Laboratories, 1979).
The OECD SIDS (2001) also reviews these studies and concludes that all present several important deficiencies. It is noted that no carcinogenic effects were observed in studies performed with sulphuric acid mist, although these studies were also considered to have been compromised by deficiencies.
A review of the available animal data by Swenberg and Beauchamp (1997) concludes that there is no evidence for the respiratory tract carcinogenicity following inhalation exposure to sulphuric acid mists.
The available data therefore indicate that sulphuric acid has the potential to act as a local, weak carcinogen following chronic exposure to relatively high levels. Findings are associated with chronic irritation at the site of contact, presumably as a consequence of the low pH of the substance. There is also some evidence that chronic local irritation induced by repeated exposures to sulphuric acid over a prolonged period of time may increase the potency of known genotoxic carcinogens, presumably due to increased cell turnover at the site of contact.
There are a relatively large number of studies investigating the link between occupational (inhalation) exposure to sulphuric acid and the incidence of tumours of the respiratory tract, and specifically the upper respiratory tract. The epidemiological data have been reviewed in the literature and also by various international bodies.
The IARC (1992) concluded, based on the available human epidemiological data, that there was sufficient evidence to support their conclusion that exposure to ‘strong inorganic acid mists containing sulphuric acid’ is carcinogenic to humans. It is notable that the IARC have not stated that sulphuric acid per se is carcinogenic. The IARC’s position was agreed by the Health Council of the Netherlands (2003), who considered the epidemiological, animal carcinogenicity and genotoxicity data, stated that sulphuric acid is likely to be a ‘non-stochastic genotoxic agent’, which is likely to exert its effect through local reduction of pH. This hypothesis was based on positive results obtained with sulphuric acid in genotoxicity assays in vitro. In contrast, the OECD SIDS for sulphuric acid (2001) cautions that the available animal data on the carcinogenicity of sulphuric acid following inhalation are negative and that confounding factors (including correction for smoking and exposure to other chemicals) complicate the interpretation of the epidemiological data. The US ATSDR (1998) concluded base on the available animal and epidemiological data, that there was no evidence to suggest that sulphuric acid by itself is carcinogenic. IARC (2009; Vol 100F) have recently changed the wording of their conclusion:
There is sufficient evidence in humans for the carcinogenicity of mists from strong inorganic acids. Mists from strong inorganic acids cause cancer of the larynx. There is limited evidence in humans for a causal association of mists from strong inorganic acids with cancer of the lung. No data in experimental animals were available to the Working Group. While it is plausible that areas of localized low pH from inhalation of inorganic acid mists could damage DNA and increase cancer risks, the evidence supporting DNA damage or any other mechanism as the cause of the observed cancers due to the inorganic acid mists is inadequate.
It is notable that this conclusion does not specifically mention sulphuric acid.
Epidemiological data
Soskolne et al (1984) investigated occupational chemical exposure to various chemicals in fifty confirmed cases of upper respiratory tract cancer. A positive association was reported between exposure to sulphuric acid and all upper respiratory tract cancers, but the association was strongest for cancer of the larynx. The same authors (Soskolne et al, 1992) report an association between prolonged exposure to high levels of sulphuric acid mists and laryngeal cancer.
A number of the studies identifying a link between sulphuric acid exposure and cancer of the upper respiratory tract were performed in workers involved in the production of ethanol and/or isopropanol. Wright (1979) cautioned that these workers are likely to have been exposed to the alkylating agent and animal carcinogen di-isopropyl sulphate and that this exposure may be an important confounding factor in these studies.
Beaumont et al (1978) investigated the mortality due to lung cancer in workers exposed to sulphuric acid (and other acid) mists in workers involved in steel pickling. The authors identified a slightly (SMR 1.39) elevated risk of lung cancer in workers exposed to sulphuric acid mist only. The risk was slightly higher (SMR 1.58) among those with daily exposure, however this was not significant when compared to a cohort of steel workers. A greater and significantly elevated risk was seen in workers exposed to acids other than sulphuric acid. Steenland (1997) followed a cohort of 1031 men exposed to acid mists in the US steel industry. Following correction for smoking incidence and alcohol consumption, a rate ratio of 2.2 was observed for laryngeal cancer. The same author (Steenland et al, 1987) reports an incidence ratio of 2.30 for laryngeal cancer in 879 male steelworkers; (Steenland & Beaumont, 1989) report an SMR of 1.56 for lung cancer in 1165 steel workers after correction for smoking incidence.
Sathiakumar et al(1997) reviewed the available epidemiological data and concluded that, in aggregate, there was a moderate association between high or moderate exposure to sulphuric acid and laryngeal cancer. They caution, however, that individual studies are imprecise and do not adequately take into account confounding factors such as smoking and exposure to other occupational chemicals.
Petrauskaite et al (2002) did not identify any increased risk of lung cancer in the general population in the vicinity of a Lithuanian sulphuric acid plant.
Parent et al (2000), reviewed 99 confirmed cases of oesophageal cancer and analysed for an association with occupational chemical exposure. The authors conclude that the data provide some support for an association with exposure to sulphuric acid.
Englander et al (1988) did not identify any increased risk of respiratory tract tumours in workers in a sulphuric acid plant. An increased incidence of bladder cancer (SMR 1.17) was identified in this study, however the authors consider this result to be spurious.
Coggon et al (1996) identified a moderately increased risk (OR 2.0) of upper aerodigestive tract cancers in men occupationally exposed to high levels of sulphuric acid or hydrochloric acid for at least five years.
Teta et al (1992) identified a slight increase in the incidence of upper respiratory tract cancer and the production of alcohol using the strong acid process but not the weak acid process.
Forastiere et al (1987) identified an increased risk of laryngeal cancer in soap production workers and suggested a link with sulphuric acid.
Alderson & Rattan (1980) performed a study of isopropanol workers in the UK and identified an increased incidence of nasal cancer. The observed increase was, however, due to a single case in the exposed cohort.
Pesatori et al (2002) investigated cancer incidence in a cohort study of Italian sulphuric acid production workers did not reveal any increased mortality from laryngeal cancer (SMR 130) or lung cancer SMR (82). An increased mortality from myeloid leukaemia (SMR 523) seen in this study is not attributable to sulphuric acid exposure.
Justification for selection of carcinogenicity via oral route endpoint:
Published study considered to be reliable
Justification for selection of carcinogenicity via inhalation route endpoint:
The endpoint has been addressed using a weight of evidence approach
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)